Works matching DE "EMTRICITABINE"

Results: 409
    1
    2
    3

    Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine.

    Published in:
    Basic & Clinical Pharmacology & Toxicology, 2019, v. 124, n. 4, p. 479, doi. 10.1111/bcpt.13161
    By:
    • Cid‐Silva, Purificación;
    • Fernández‐Bargiela, Noelia;
    • Margusino‐Framiñán, Luis;
    • Balboa‐Barreiro, Vanesa;
    • Mena‐De‐Cea, Álvaro;
    • López‐Calvo, Soledad;
    • Vázquez‐Rodríguez, Pilar;
    • Martín‐Herranz, Isabel;
    • Míguez‐Rey, Enrique;
    • Poveda, Eva;
    • Castro‐Iglesias, Ángeles
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Repeated rectal application of a hyperosmolar lubricant is associated with microbiota shifts but does not affect PrEP drug concentrations: results from a randomized trial in men who have sex with men.

    Published in:
    Journal of the International AIDS Society, 2018, v. 21, n. 10, p. N.PAG, doi. 10.1002/jia2.25199
    By:
    • Haaland, Richard E;
    • Fountain, Jeffrey;
    • Hu, Yingtian;
    • Holder, Angela;
    • Dinh, Chuong;
    • Hall, LaShonda;
    • Pescatore, Nicole A;
    • Heeke, Sheila;
    • Hart, Clyde E;
    • Xu, Jiahui;
    • Hu, Yi‐Juan;
    • Kelley, Colleen F
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22

    Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort Study.

    Published in:
    Canadian Journal of Hospital Pharmacy / Journal Canadien de la Pharmacie Hospitalière, 2022, v. 75, n. 4, p. 309, doi. 10.4212/cjhp.3234
    By:
    • McClean, Alison R.;
    • Trigg, Jason;
    • Cardinal, Claudette;
    • Loutfy, Mona;
    • Cooper, Curtis;
    • Kroch, Abigail;
    • Shokoohi, Mostafa;
    • Machouf, Nimâ;
    • Thomas, Réjean;
    • Klein, Marina B.;
    • Kelly, Deborah V.;
    • Wong, Alexander;
    • Sanche, Stephen;
    • Montaner, Julio S. G.;
    • Hogg, Robert S.
    Publication type:
    Article
    23
    24

    A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trial.

    Published in:
    2020
    By:
    • Iwuji, Collins C.;
    • Churchill, Duncan;
    • Bremner, Stephen;
    • Perry, Nicky;
    • To, Ye;
    • Lambert, Debbie;
    • Bruce, Chloe;
    • Waters, Laura;
    • Orkin, Chloe;
    • Geretti, Anna Maria
    Publication type:
    journal article
    25

    Age: HIV knows no boundary.

    Published in:
    2014
    By:
    • Smibert, Olivia C.;
    • Ananda-Rajah, Michelle;
    • O'Brien, Jessica;
    • Visvanathan, Kumar
    Publication type:
    Case Study
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial.

    Published in:
    2017
    By:
    • Fonsart, Julien;
    • Saragosti, Sentob;
    • Taouk, Milad;
    • Peytavin, Gilles;
    • Bushman, Lane;
    • Charreau, Isabelle;
    • Hance, Allan;
    • Goldwirt, Lauriane;
    • Morel, Stéphane;
    • Mammano, Fabrizio;
    • Loze, Bénédicte;
    • Capitant, Catherine;
    • Clavel, François;
    • Mahjoub, Nadia;
    • Meyer, Laurence;
    • Anderson, Peter L.;
    • Delaugerre, Constance;
    • Molina, Jean-Michel
    Publication type:
    journal article
    36
    37
    38

    Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 12, p. 3323, doi. 10.1093/jac/dkv276
    By:
    • Wan-Lin Yang;
    • Kouyos, Roger D.;
    • Scherrer, Alexandra U.;
    • Böni, Jürg;
    • Shah, Cyril;
    • Yerly, Sabine;
    • Klimkait, Thomas;
    • Aubert, Vincent;
    • Hirzel, Cédric;
    • Battegay, Manuel;
    • Cavassini, Matthias;
    • Bernasconi, Enos;
    • Vernazza, Pietro;
    • Held, Leonhard;
    • Ledergerber, Bruno;
    • Günthard, Huldrych F.
    Publication type:
    Article
    39
    40
    41

    Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 6, p. 1850, doi. 10.1093/jac/dkv033
    By:
    • Swartz, J. E.;
    • Vandekerckhove, L.;
    • Ammerlaan, H.;
    • de Vries, A. C.;
    • Begovac, J.;
    • Bierman, W. F. W.;
    • Boucher, C. A. B.;
    • van der Ende, M. E.;
    • Grossman, Z.;
    • Kaiser, R.;
    • Levy, I.;
    • Mudrikova, T.;
    • Paredes, R.;
    • Perez-Bercoff, D.;
    • Pronk, M.;
    • Richter, C.;
    • Schmit, J. C.;
    • Vercauteren, J.;
    • Zazzi, M.;
    • Lepej, S. Židovec
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48

    Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 1, p. 200
    By:
    • Di Biagio, Antonio;
    • Prinapori, Roberta;
    • Giannarelli, Diana;
    • Maggiolo, Franco;
    • Di Giambenedetto, Simona;
    • Borghi, Vanni;
    • Penco, Giovanni;
    • Cicconi, Paola;
    • Francisci, Daniela;
    • Sterrantino, Gaetana;
    • Zoncada, Alessia;
    • Monno, Laura;
    • Capetti, Amedeo;
    • Giacometti, Andrea
    Publication type:
    Article
    49
    50